CSL hits speed bump in Vifor deal

Posted 13 May 2022 AM

CSL has hit a speed bump in its acquisition of Swiss company Vifor Pharma.

The local giant had previously indicated that it expected the deal to close by June this year, but yesterday it released a statement on the ASX saying it "now expects the regulatory approval process to take a few more months".

To see the whole article, please login

Popular

Who got booted to the May meet?

Best company Christmas gift is...

First out the door in '25?

He's back: Ex-GM wins CEO role

Latest Jobs

Medical Sales Representative

Customer Service Representative

QC Scientist

QC Analytical Technology Scientist (Chemistry)

AUSTRALIAN TECHNICAL ADVISORY GROUP ON IMMUNISATION

See all...

Pharma in Focus Jobs

Marketing & Communications (1)

Sales and Marketing Administrator/PA - Nunawading

Sales & Customer Relations (12)

Clinical & Medical, R&D (10)

Regulatory, Pharmacovigilance & QA (2)

Other (8)

MORE NEWS

Email this article to a friend

From:

Subject

Friend's email

Message to go with the article

Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.

Skip password for now